We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$2.13B
(+17%)
Cap. Flow
+$1.52B
Cap. Flow
% of AUM
10.28%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
1,089
New
119
Increased
321
Reduced
473
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$132M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$100M |
| 4 |
Fidelity National Information Services
FIS
|
+$94.3M |
| 5 |
FedEx
FDX
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$97.2M |
| 2 |
Booking.com
BKNG
|
+$94.2M |
| 3 |
Phillips 66
PSX
|
+$82.9M |
| 4 |
Gilead Sciences
GILD
|
+$73.9M |
| 5 |
Snowflake
SNOW
|
+$51.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.09% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Evolent Health
EVH
$421M
| $739K | 0.01% |
26,310
-202,145
| -88% | -$5.79M |
|
727
IDT Corp
IDT
$1.69B
| $723K | ﹤0.01% |
25,666
| – | – |
|
728
Inseego
INSG
$111M
| $722K | ﹤0.01% |
+85,684
| New | +$1.29M |
|
729
BCB Bancorp
BCBP
$186M
| $716K | ﹤0.01% |
39,798
-4,691
| -11% | -$87.8K |
|
730
Ciena
CIEN
$49.6B
| $715K | ﹤0.01% |
14,016
-62,847
| -82% | -$2.84M |
|
|
PVBC
731
DELISTED
Provident Bancorp
PVBC
| $713K | ﹤0.01% |
+97,896
| New | +$993K |
|
732
W.W. Grainger
GWW
$66B
| $708K | ﹤0.01% |
+1,272
| New | +$718K |
|
733
Enviri
NVRI
$623M
| $694K | ﹤0.01% |
110,277
+92,035
| +505% | +$548K |
|
|
KZR
734
DELISTED
Kezar Life Sciences
KZR
| $693K | ﹤0.01% |
9,845
+1,908
| +24% | +$141K |
|
|
PACW
735
DELISTED
PacWest Bancorp
PACW
| $692K | ﹤0.01% |
30,148
-107,529
| -78% | -$2.61M |
|
|
SOVO
736
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $688K | ﹤0.01% |
47,905
-143,086
| -75% | -$2M |
|
737
HBT Financial
HBT
$1.31B
| $687K | ﹤0.01% |
35,092
-295
| -0.8% | -$5.81K |
|
738
Tandem Diabetes Care
TNDM
$1.22B
| $685K | ﹤0.01% |
+15,229
| New | +$689K |
|
739
Global Industrial
GIC
$1.39B
| $661K | ﹤0.01% |
+28,073
| New | +$728K |
|
740
Mercantile Bank Corp
MBWM
$1.04B
| $660K | ﹤0.01% |
19,725
-465
| -2% | -$15.6K |
|
741
Coastal Financial
CCB
$1.11B
| $658K | ﹤0.01% |
13,851
+621
| +5% | +$28.8K |
|
|
ALBO
742
DELISTED
Albireo Pharma Inc
ALBO
| $652K | ﹤0.01% |
+30,165
| New | +$638K |
|
|
UDMY
743
DELISTED
Udemy
UDMY
| $647K | ﹤0.01% |
61,287
+40,847
| +200% | +$552K |
|
744
Sierra Bancorp
BSRR
$531M
| $645K | ﹤0.01% |
30,388
-422
| -1% | -$9.04K |
|
745
Investar Holding Corp
ISTR
$415M
| $643K | ﹤0.01% |
29,882
-10,542
| -26% | -$226K |
|
746
Camden National
CAC
$977M
| $639K | ﹤0.01% |
15,331
-3,807
| -20% | -$162K |
|
747
DigitalOcean
DOCN
$13.2B
| $638K | ﹤0.01% |
25,044
-87,200
| -78% | -$2.73M |
|
748
Century Therapeutics
IPSC
$370M
| $636K | ﹤0.01% |
+123,996
| New | +$1.17M |
|
749
Primis Financial Corp
FRST
$398M
| $635K | ﹤0.01% |
53,604
-5,236
| -9% | -$64.3K |
|
750
Ceco Environmental
CECO
$3.94B
| $631K | ﹤0.01% |
54,026
| – | – |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2022 Portfolio in Review
As of Q4 2022, Jacobs Levy Equity Management held 1,089 positions worth $14.8B, up 17% from $12.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.52B of net new capital in Q4 2022, opening 119 new positions and adding to 321 existing holdings. Its largest new stake was Fidelity National Information Services: 1,326,663 shares worth $90M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Booking.com, an estimated $94.2M trimmed.
- Jacobs Levy Equity Management's largest Q4 2022 buy was Fidelity National Information Services: 1,326,663 shares worth $90M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q4 2022, an estimated $132M increase.
- Jacobs Levy Equity Management's biggest Q4 2022 reduction was Booking.com, cutting an estimated $94.2M.
- Jacobs Levy Equity Management fully exited Cigna in Q4 2022, selling an estimated $97.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q4 2022.
- Jacobs Levy Equity Management opened 119 new positions and closed 155 in Q4 2022.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.